YU37316B - Process for obtaining a substituted cyclopentane derivative - Google Patents

Process for obtaining a substituted cyclopentane derivative

Info

Publication number
YU37316B
YU37316B YU2706/80A YU270680A YU37316B YU 37316 B YU37316 B YU 37316B YU 2706/80 A YU2706/80 A YU 2706/80A YU 270680 A YU270680 A YU 270680A YU 37316 B YU37316 B YU 37316B
Authority
YU
Yugoslavia
Prior art keywords
obtaining
substituted cyclopentane
cyclopentane derivative
derivative
substituted
Prior art date
Application number
YU2706/80A
Other languages
English (en)
Other versions
YU270680A (en
Inventor
J S Bindra
M R Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU270680A publication Critical patent/YU270680A/xx
Publication of YU37316B publication Critical patent/YU37316B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU2706/80A 1972-11-08 1980-10-23 Process for obtaining a substituted cyclopentane derivative YU37316B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481372A 1972-11-08 1972-11-08

Publications (2)

Publication Number Publication Date
YU270680A YU270680A (en) 1983-04-27
YU37316B true YU37316B (en) 1984-08-31

Family

ID=23178133

Family Applications (3)

Application Number Title Priority Date Filing Date
YU2880/73A YU39715B (en) 1972-11-08 1973-11-07 Process for obtaining substituted omega-pentanoprostaglandins
YU2707/80A YU36975B (en) 1972-11-08 1980-10-23 Process for obtaining dimethyl-2-oxo-3-phenoxypropylphosphonate
YU2706/80A YU37316B (en) 1972-11-08 1980-10-23 Process for obtaining a substituted cyclopentane derivative

Family Applications Before (2)

Application Number Title Priority Date Filing Date
YU2880/73A YU39715B (en) 1972-11-08 1973-11-07 Process for obtaining substituted omega-pentanoprostaglandins
YU2707/80A YU36975B (en) 1972-11-08 1980-10-23 Process for obtaining dimethyl-2-oxo-3-phenoxypropylphosphonate

Country Status (29)

Country Link
JP (3) JPS5416491B2 (xx)
AR (3) AR200585A1 (xx)
AT (3) AT367034B (xx)
AU (1) AU470375B2 (xx)
BE (1) BE806995A (xx)
CA (3) CA1085831A (xx)
CH (1) CH597176A5 (xx)
CS (3) CS182791B2 (xx)
DD (4) DD118856A5 (xx)
DE (1) DE2355540C2 (xx)
DK (1) DK144247C (xx)
ES (3) ES420325A1 (xx)
FI (1) FI60389C (xx)
FR (3) FR2205335B1 (xx)
GB (3) GB1456512A (xx)
HK (3) HK27979A (xx)
HU (3) HU171819B (xx)
IE (1) IE39537B1 (xx)
IL (1) IL43589A (xx)
IN (1) IN139384B (xx)
KE (3) KE2932A (xx)
MY (3) MY7900243A (xx)
NL (1) NL164273C (xx)
NO (3) NO147836C (xx)
PH (3) PH13272A (xx)
SE (4) SE448992B (xx)
SU (4) SU584766A3 (xx)
YU (3) YU39715B (xx)
ZA (1) ZA738554B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
GB1506816A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
US3986764A (en) * 1975-03-31 1976-10-19 Gte Automatic Electric Laboratories Incorporated Panel for supporting a pair of elongated mating connectors and selectively locking them together
ES449162A1 (es) * 1975-06-23 1977-12-16 Syntex Inc Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
GB1516414A (en) * 1975-08-22 1978-07-05 Ici Ltd Prostane derivatives
SE7809008L (sv) * 1977-12-12 1979-06-13 Upjohn Co Anvendning av amider av prostaglandintyp for att styra eller reglera reproduktionscykeln hos individer tillhorande deggdjursarter
DK523378A (da) * 1978-01-16 1979-07-17 Pfizer Fremgangsmaade til fremstilling af n-(tetrazol-5-yl) prostaglandin-carboxamider eller salte deraf
SK3382000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders
JP4834224B2 (ja) 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
JP2002329615A (ja) * 2001-05-02 2002-11-15 Ohira Denshi Kk トロイダルコイル
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
EP1812017A2 (en) 2004-10-21 2007-08-01 Duke University Ophthamological drugs
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives

Also Published As

Publication number Publication date
SU667141A3 (ru) 1979-06-05
CA1085831A (en) 1980-09-16
AT367034B (de) 1982-05-25
CH597176A5 (xx) 1978-03-31
SU893130A3 (ru) 1981-12-23
NL7315263A (xx) 1974-05-10
DE2355540C2 (de) 1982-11-18
ES433047A1 (es) 1976-11-01
SE448992B (sv) 1987-03-30
SU584766A3 (ru) 1977-12-15
FI60389B (fi) 1981-09-30
SE7700716L (sv) 1977-01-24
IN139384B (xx) 1976-06-12
DD119411A5 (xx) 1976-04-20
DE2365322B2 (de) 1977-02-24
AU6224773A (en) 1975-05-08
SE7700717L (sv) 1977-01-24
FR2279729A1 (fr) 1976-02-20
DK144247B (da) 1982-01-25
HK28079A (en) 1979-05-11
FR2279729B1 (xx) 1978-04-28
ATA936973A (de) 1981-10-15
NO148998B (no) 1983-10-17
BE806995A (fr) 1974-05-07
FR2205335A1 (xx) 1974-05-31
DE2365322A1 (de) 1974-11-07
MY7900246A (en) 1979-12-31
AR199966A1 (es) 1974-10-08
HU173507B (hu) 1979-05-28
SE436278B (sv) 1984-11-26
KE2932A (en) 1979-03-30
PH13325A (en) 1980-03-13
DD117233A5 (xx) 1976-01-05
YU36975B (en) 1984-08-31
HU171819B (hu) 1978-03-28
NO750535L (xx) 1974-05-09
ATA544676A (de) 1979-04-15
SU745362A3 (ru) 1980-06-30
GB1456513A (en) 1976-11-24
NO743493L (no) 1974-05-09
SE445111B (sv) 1986-06-02
DE2355540A1 (de) 1974-05-22
FR2205335B1 (xx) 1978-07-13
NO149139C (no) 1984-02-29
IL43589A0 (en) 1974-03-14
YU270680A (en) 1983-04-27
YU39715B (en) 1985-04-30
JPS5257147A (en) 1977-05-11
YU288073A (en) 1982-02-28
DK144247C (da) 1982-07-12
YU270780A (en) 1982-06-18
AR200585A1 (es) 1974-11-22
AT360672B (de) 1981-01-26
MY7900243A (en) 1979-12-31
KE2931A (en) 1979-03-30
SE7700718L (sv) 1977-01-24
CS182794B2 (en) 1978-05-31
AT353285B (de) 1979-11-12
JPS5416491B2 (xx) 1979-06-22
NO147836B (no) 1983-03-14
HK27979A (en) 1979-05-11
CA1088930A (en) 1980-11-04
CA1088931A (en) 1980-11-04
IE39537B1 (en) 1978-11-08
JPS4993342A (xx) 1974-09-05
FR2283146B1 (xx) 1981-06-19
NL164273C (nl) 1980-12-15
NO149139B (no) 1983-11-14
GB1456512A (en) 1976-11-24
GB1456514A (en) 1976-11-24
AU470375B2 (en) 1976-03-11
IE39537L (en) 1974-05-08
SE431756B (sv) 1984-02-27
HK28179A (en) 1979-05-11
CS182793B2 (en) 1978-05-31
ES420325A1 (es) 1976-04-16
ES433046A1 (es) 1977-06-16
NO148998C (no) 1984-01-25
IL43589A (en) 1980-01-31
ZA738554B (en) 1974-09-25
JPS5253841A (en) 1977-04-30
CS182791B2 (en) 1978-05-31
HU172703B (hu) 1978-11-28
KE2930A (en) 1979-03-30
MY7900245A (en) 1979-12-31
DD118856A5 (xx) 1976-03-20
DD109212A5 (xx) 1974-10-20
FI60389C (fi) 1982-01-11
PH13272A (en) 1980-02-27
NO147836C (no) 1983-06-22
ATA544576A (de) 1980-06-15
FR2283146A1 (fr) 1976-03-26
PH13110A (en) 1979-11-28
AR202931A1 (es) 1975-07-31

Similar Documents

Publication Publication Date Title
JPS5387385A (en) Process for preparing benzodiazokyne derivative
YU37358B (en) Process for producing rapamycin
YU210773A (en) Process for obtaining imidazoquinazolin-2-one derivatives
YU37316B (en) Process for obtaining a substituted cyclopentane derivative
YU313273A (en) Process for obtaining new delta-glutamyl-p-nitroanilide compounds
YU133872A (en) Process for obtaining diphenyl-alkanoylamino-pyridines
YU36527B (en) Process for obtaining 3-hydroxy-cephalosporin
YU3473A (en) Process for obtaining delta-aryl-4-substituted piperidinoalkanol derivatives
YU296173A (en) Process for obtaining new alkylthiocyclopentanone derivatives
YU35452B (en) Process for obtaining d-homosteroids
YU200973A (en) Process for obtaining a novel antibiotic
HU172069B (hu) Sposob poluchenija proizvodnykh 1-skobka-3-dvojjnozamehhennykh-fosfono-tioureido-skobka zakryta-2-skobka-3-zamehhennykh-ureido- ili -tioureido-skobka zakryta-benzolov
YU36149B (en) Process for obtaining isopropylamines
YU299479A (en) Process for obtaining novel aminoimidazoloisoquinoline derivatives
HU167876B (en) Process for producing 9-10-secoestrane derivatives
PH13200A (en) A method for producing deacetokycephalosporin c
HU173381B (hu) Sposob poluchenija proizvodnykh karboksi-ciklopropanov
YU265573A (en) Process for obtaining a new antibiotic
YU146973A (en) Process for obtaining oxo-prostaglandins
YU318473A (en) Process for obtaining m-dioxane-5-methylamines
YU102673A (en) Process for obtaining rifamycine b
YU36972B (en) Process for obtaining 7-acylamido-7-alkoxycephalosporins
YU240180A (en) Process for obtaining deacetoxy-cephalosporin
YU35273B (en) Process for obtaining bicyclomycine
YU113673A (en) Process for obtaining novel 1-acyl-homo-pyrimidazole derivatives